Prerana Jha

发表

Analysis of PD‐L1 expression and T cell infiltration in different molecular subgroups of diffuse midline gliomas

C. Sarkar, M. Sharma, K. Mani, 2019, Neuropathology : official journal of the Japanese Society of Neuropathology.

O6-Methylguanine DNA Methyltransferase Gene Promoter Methylation Status in Gliomas and Its Correlation With Other Molecular Alterations: First Indian Report With Review of Challenges for Use in Customized Treatment

C. Sarkar, M. Sharma, P. Chattopadhyay, 2010, Neurosurgery.

Limb girdle muscular dystrophy type 2A in India: a study based on semi-quantitative protein analysis, with clinical and histopathological correlation.

C. Sarkar, M. Sharma, R. Bhatia, 2010, Neurology India.

Pediatric High Grade Glioma

C. Sarkar, S. Purkait, P. Pathak, 2017 .

A simplified approach for molecular classification of glioblastomas (GBMs): experience from a tertiary care center in India

C. Sarkar, M. Sharma, Anupam Kumar, 2016, Brain Tumor Pathology.

High-Grade Gliomas

C. Q. Lee, David T. W. Jones, Michael D. Brooks, 2012, Oxford Medicine Online.

Genome‐wide small noncoding RNA profiling of pediatric high‐grade gliomas reveals deregulation of several miRNAs, identifies downregulation of snoRNA cluster HBII‐52 and delineates H3F3A and TP53 mutant‐specific miRNAs and snoRNAs

Pankaj Pathak, Ashish Suri, Chitra Sarkar, 2015, International journal of cancer.

Altered global histone-trimethylation code and H3F3A-ATRX mutation in pediatric GBM

C. Sarkar, M. Sharma, M. Faruq, 2015, Journal of Neuro-Oncology.

A clinicopathological and molecular analysis of glioblastoma multiforme with long-term survival

C. Sarkar, M. Sharma, A. Mahapatra, 2011, Journal of Clinical Neuroscience.

Long Non-coding RNA and mRNA Co-expression Network Reveals Novel Players in Pleomorphic Xanthoastrocytoma

C. Sarkar, M. Sharma, R. Kulshreshtha, 2022, Molecular Neurobiology.

O6 -methylguanine DNA methyltransferase gene promoter methylation in high-grade gliomas: a review of current status.

C. Sarkar, M. Sharma, V. Suri, 2011, Neurology India.

Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing

C. Sarkar, R. Kulshreshtha, Priyatama Pandey, 2014, BMC Genomics.

Comparative study of IDH1 mutations in gliomas by immunohistochemistry and DNA sequencing.

Pankaj Pathak, Ashish Suri, Chitra Sarkar, 2013, Neuro-oncology.

Comparative study of IDH 1 mutations in gliomas by immunohistochemistry and DNA sequencing

C. Sarkar, M. Sharma, A. Mahapatra, 2013 .

IDH1 mutations in gliomas: first series from a tertiary care centre in India with comprehensive review of literature.

C. Sarkar, M. Sharma, A. Mahapatra, 2011, Experimental and molecular pathology.

Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing

C. Sarkar, R. Kulshreshtha, Priyatama Pandey, 2014, BMC Genomics.

Clinico-pathological and molecular characterization of diffuse midline gliomas: is there a prognostic significance?

C. Sarkar, M. Sharma, K. Mani, 2020, Neurological Sciences.

Genome-wide methylation profiling identifies an essential role of reactive oxygen species in pediatric glioblastoma multiforme and validates a methylome specific for H3 histone family 3A with absence of G-CIMP/isocitrate dehydrogenase 1 mutation.

C. Sarkar, M. Sharma, K. Somasundaram, 2014, Neuro-oncology.

Characterization of Molecular Genetic Alterations in GBMs Highlights a Distinctive Molecular Profile in Young Adults

C. Sarkar, M. Sharma, A. Mahapatra, 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Molecular profile of oligodendrogliomas in young patients.

C. Sarkar, M. Sharma, A. Mahapatra, 2011, Neuro-oncology.

ATRX in Diffuse Gliomas With its Mosaic/Heterogeneous Expression in a Subset

R. Fulton, C. Sarkar, M. Sharma, 2017, Brain pathology.

CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry

C. Sarkar, M. Sharma, V. Suri, 2013, Neuropathology : official journal of the Japanese Society of Neuropathology.

Loss of heterozygosity on chromosome 10q in glioblastomas, and its association with other genetic alterations and survival in Indian patients.

C. Sarkar, M. Sharma, V. Suri, 2011, Neurology India.

Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.

C. Sarkar, M. Sharma, A. Suri, 2010, Cancer genetics and cytogenetics.

KLF2 in Regulation of NF-κB-Mediated Immune Cell Function and Inflammation

H. Das, Prerana Jha, 2017, International journal of molecular sciences.

MGMT gene promoter methylation in pediatric glioblastomas

C. Sarkar, M. Sharma, Arti Srivastava, 2010, Child's Nervous System.

Genetic alterations related to BRAF‐FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma

C. Sarkar, M. Sharma, M. Faruq, 2017, Brain pathology.

EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB‐1 proliferation index

C. Sarkar, M. Sharma, A. Suri, 2015, Neuropathology : official journal of the Japanese Society of Neuropathology.

Prognostic Stratification of GBMs Using Combinatorial Assessment of IDH1 Mutation, MGMT Promoter Methylation, and TERT Mutation Status: Experience from a Tertiary Care Center in India1

C. Sarkar, M. Sharma, Anupam Kumar, 2016, Translational oncology.

TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.

C. Sarkar, M. Sharma, A. Mahapatra, 2011, Experimental and molecular pathology.

Genome-wide analysis reveals downregulation of miR-379/miR-656 cluster in human cancers

Arijit Mukhopadhyay, Anurag Agrawal, Chitra Sarkar, 2013, Biology Direct.

Expression of DNA methyltransferases 1 and 3B correlates with EZH2 and this 3-marker epigenetic signature predicts outcome in glioblastomas.

C. Sarkar, M. Sharma, Anupam Kumar, 2016, Experimental and molecular pathology.

Gene expression based profiling of pleomorphic xanthoastrocytoma highlights two prognostic subgroups.

C. Sarkar, M. Sharma, R. Kulshreshtha, 2022, American journal of translational research.

Detection of Allelic Status of 1p and 19q by Microsatellite-based PCR Versus FISH: Limitations and Advantages in Application to Patient Management

C. Sarkar, M. Sharma, V. Suri, 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Meningeal hemangiopericytomas: A clinicopathological study with emphasis on MGMT (O6‐methylguanine‐DNA methyltransferase) promoter methylation status

C. Sarkar, M. Sharma, N. Goyal, 2014, Neuropathology : official journal of the Japanese Society of Neuropathology.

A study of clinico‐pathological parameters and O6 – methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma

C. Sarkar, Nikhil Joshi, M. Sharma, 2012, Neuropathology : official journal of the Japanese Society of Neuropathology.

Mutational Spectrum of CAPN3 with Genotype-Phenotype Correlations in Limb Girdle Muscular Dystrophy Type 2A/R1 (LGMD2A/LGMDR1) patients in India.

C. Sarkar, M. Sharma, M. Faruq, 2020, Journal of neuromuscular diseases.

Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas.

C. Sarkar, M. Sharma, M. Faruq, 2015, Cancer genetics.

Molecular Characterization of IDH Wild-type Diffuse Astrocytomas: The Potential of cIMPACT-NOW Guidelines

C. Sarkar, M. Sharma, Kavneet Kaur, 2022, Applied immunohistochemistry & molecular morphology : AIMM.

Pediatric High Grade Glioma

C. Sarkar, S. Purkait, P. Pathak, 2017 .

Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres

C. Sarkar, M. Sharma, Kavneet Kaur, 2019, Journal of Neuro-Oncology.

High grade gliomas

C. Q. Lee, David T. W. Jones, Michael D. Brooks, 2022, Progress in Brain Research.